Cellebrite DI Ltd. (CLBT) insider trading.
In Q3 2026, insiders at Cellebrite DI Ltd. reported 18 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $5.0M.
- Transactions
- 18
- Purchases (P)
- 0
- Sales (S)
- 9
- Net shares, P minus S
- -329,658
- Insiders
- 12
- Last filed
- 2026-09-29
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Hogan Thomas E. | Other | 4 | 0 | 3 |
| Gee David Nicholas | Officer · Chief Marketing Officer | 3 | 0 | 3 |
| Jewell Marcus | Officer · Global Chief Revenue Officer | 2 | 0 | 2 |
| Ramji Shiven | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
| Domnitz Yonatan | Director | 1 | 0 | 0 |
| Utsumi Ryusuke | Director | 1 | 0 | 0 |
| Clammer Adam | Director | 1 | 0 | 0 |
| Baudot-Trajtenberg Nadine | Director | 1 | 0 | 0 |
| Gruber Dafna | Director | 1 | 0 | 0 |
| Richardson Troy | Director | 1 | 0 | 0 |
| Van Buren Brandon | Director | 1 | 0 | 0 |
| Barter David | Officer · Chief Financial Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-24 | Ramji Shiven | A (A) | 38,505 | $0 | 462,055 | Form 4 |
| 2026-09-17 | Domnitz Yonatan | A (A) | 15,190 | $0 | 86,586 | Form 4 |
| 2026-09-17 | Utsumi Ryusuke | A (A) | 15,190 | $0 | 66,586 | Form 4 |
| 2026-09-17 | Clammer Adam | A (A) | 15,190 | $0 | 86,586 | Form 4 |
| 2026-09-17 | Baudot-Trajtenberg Nadine | A (A) | 15,190 | $0 | 50,744 | Form 4 |
| 2026-09-17 | Gruber Dafna | A (A) | 15,190 | $0 | 43,109 | Form 4 |
| 2026-09-17 | Richardson Troy | A (A) | 15,190 | $0 | 36,164 | Form 4 |
| 2026-09-17 | Van Buren Brandon | A (A) | 15,190 | $0 | 50,744 | Form 4 |
| 2026-08-25 | Hogan Thomas E. | S (D) | 25,299 | $11.29 | 765,249 | Form 4 |
| 2026-08-24 | Gee David Nicholas | S (D) | 4,323 | $11.36 | 135,281 | Form 4 |
| 2026-08-21 | Gee David Nicholas | S (D) | 2,198 | $11.24 | 139,604 | Form 4 |
| 2026-08-21 | Jewell Marcus | S (D) | 12,562 | $11.24 | 427,128 | Form 4 |
| 2026-08-12 | Gee David Nicholas | S (D) | 230 | $16.07 | 141,802 | Form 4 |
| 2026-08-12 | Jewell Marcus | S (D) | 411 | $16.07 | 439,690 | Form 4 |
| 2026-08-12 | Hogan Thomas E. | S (D) | 139,713 | $15.39 | 790,548 | Form 4 |
| 2026-08-11 | Hogan Thomas E. | A (A) | 339,484 | $0 | 930,261 | Form 4 |
| 2026-07-08 | Barter David | S (D) | 41,734 | $16.38 | 334,219 | Form 4 |
| 2026-07-02 | Hogan Thomas E. | S (D) | 103,188 | $15.76 | 590,777 | Form 4 |
Transaction codes in this quarter
Get CLBT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1854587&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CLBT company page · Cellebrite DI Ltd. on SEC.gov
Questions
Are insiders buying or selling Cellebrite DI Ltd. (CLBT)?
In Q3 2026, insiders at Cellebrite DI Ltd. reported 18 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $5.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Cellebrite DI Ltd. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/clbt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.